Skip to main content

Table 3 Seroprevalences by operational areas

From: Phlebovirus seroprevalence in Austrian Army personnel returning from missions abroad

 

Titer ≥ 1:10

Titer ≥ 1:20

Titer ≥ 1:100

IgG positive/Total (%)

OR/95% CI

(P-value)

IgG positive/Total (%)

OR/95% CI

(P-value)

IgG positive/Total (%)

OR/95% CI

(P-value)

Soldiers before missions

31/267

(11.6)

Reference

23/267

(8.6%)

Reference

12/267

(4.5)

Reference

BIH

7/61

(11.5)

1.0/0.4–2.5

(1.0)

7/61

(11.5%)

1.4/0.5–3.5

(0.46)

3/61

(4.9)

1.1/0.2–4.3

(1.0)

Kosovo

54/261

(20.7)

1.9/1.2–3.2

(0.006)*

31/261

(11.9%)

1.5/0.8–2.7

(0.25)

14/261

(5.4)

1.2/0.5–2.9

(0.70)

Syria

18/101

(17.8)

1.7/0.8–3.2

(0.12)

15/101

(14.9%)

2.0/0.9–4.3

(0.05)*

8/101

(7.9)

1.8/0.6–5.0

(0.20)

Lebanon

9/63

(14.3)

1.3/0.5–3.0

(0.50)

8/63

(12.7)

1.7/0.6–4.2

(0.22)

6/63

(9.5)

2.23/0.7–6.8

(0.13)

  1. * Significant result (P < 0.05)